King Elizabeth Kathryn has filed a Form 144 to sell 1,919 shares of Intercontinental Exchange, Inc. This filing, made on November 4, 2026, is significant as it reflects both personal financial decisions and broader trends in the securities industry.
Intercontinental Exchange, Inc. operates within the security and commodity brokers, dealers, exchanges, and services sector. The company's recent filings indicate a focus on transparency and regulatory compliance as it navigates the complexities of the financial markets.
Background
King Elizabeth Kathryn is associated with Intercontinental Exchange, Inc., which is listed under the Central Index Key 0001571949. The company is primarily involved in the financial services industry, specifically focusing on securities and commodities. The recent filing history includes several transactions, with the latest being the Form 144 filed on November 4, 2026, under accession number 0001950047-26-010711.
What the Filing Says
The filing details the sale of 1,919 shares of common stock, with an aggregate market value of approximately $328,014.67. The shares were acquired through an Employee Stock Purchase Plan on December 29, 2023, and through Performance Stock Units on February 12, 2025. The filing notes, "The securities to be sold were acquired under the employee stock purchase plan on 12/29/2023 and 6/28/2024." This indicates that the shares being sold were part of a planned financial strategy.
Impact
This transaction may affect market perceptions of Intercontinental Exchange, Inc. as it reflects the financial decisions of an officer within the company. Such insider transactions can influence investor sentiment and market dynamics, particularly in the context of the broader securities industry.
What's Next
The filing does not say what happens next.
Read Next
Andersen Aggregator files new offering for internal reorganization
HSBC USA Inc. Files Pricing Supplement for New Notes
Mkango Rare Earths files prospectus for merger with CPTK
Evommune files prospectus supplement for capital update
Yum Brands officer Erika Burkhardt files to sell shares
Matsuda Masaru to Sell 40,000 Shares of Arcutis Biotherapeutics




